Faculty of Medicine

Academic Members

Hasan Mutlu

Hasan Mutlu,  Prof.

Öğretim Üyesi

He studied at Hacettepe University Faculty of Medicine. After graduating in 1999, he started as fellow at the department of Internal Medicine and then Medical Oncology at Akdeniz University School of Medicine. After the Internal Medicine and Medical Oncology specialty training, he started to work as Medical Oncologist at the Research and Training Hospital for compulsory service. After compulsory service, he worked Acibadem Kayseri Hospital and then he returmed to the deparment of Medical Oncoloy at the Akdeniz University School of Medicine in 2013. He received the title of Associate Professor in 2014. He left academia in 2017 and started working full time at Private Lara Anatolian Hospital. He started at Medicalpark Antalya Hospital in 2018 and at Istinye University in 2019. He received title of Professor at Istinye University in 2019. As the first name, he has published more than 30 original articles and he has contrubited more than 100 works in worldwide.

Research Areas: Cancer, Cancer treatment

Main Areas: Tıbbi Onkoloji, 

2015 - Is there any relation between PET CT SUVmax value and prognostic factors in locally advanced breast cancer
TURAL DENİZ,KIVRAK SALİM DERYA,MUTLU HASAN,GÜNDÜZ ŞEYDA,KARAKURT ERYILMAZ MELEK,FATMA YALÇIN MUSRİ,TUNA S,HAKAN BOZCUK,COŞKUN HASAN ŞENOL. Journal of B.U.ON, 5(20), 1282-1285.
2015 - The role of blood groups in the development of diabetes mellitus after gestational diabetes mellitus
KARAGÖZ H,ERDEN ABDULSAMET,ÖZER O,ESMERAY K,ÇETİNKAYA A,AVCI D,KARAHAN S,BAŞAK M,BULUT K,MUTLU HASAN,ŞİMŞEK Y. Therapeutics and clinical risk management, 1613-1617.
2015 - Docetaxel plus cisplatin plus fluorouracil versus carboplatin plus fluorouracil cetuximab in first line setting in patients with recurrent or metastatic head and neck squamous cell cancer who did not previously receive neoadjuvant or adjuvant chemotherapy which is standard
MUTLU HASAN,KIVRAK SALİM DERYA,GÜNDÜZ ŞEYDA,KARAKURT ERYILMAZ MELEK,FATMA YALÇIN MUSRİ,COŞKUN HASAN ŞENOL. Journal of cancer research and therapeutics,
2015 - Platelet to lymphocyte ratio as a new prognostic for patients with metastatic renal cell cancer
GÜNDÜZ ŞEYDA,MUTLU HASAN,TURAL DENİZ,YILDIZ ÖZCAN,UYSAL MÜKREMİN,COŞKUN HASAN ŞENOL,HAKAN BOZCUK,SEZGİN GÖKSU SEMA. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 11(4), 288-92.
2015 - Neutrophil to lymphocyte ratio is an independent prognostic factor in patients with recurrent or metastatic head and neck squamous cell cancer
KIVRAK SALİM DERYA,MUTLU HASAN,KARAKURT ERYILMAZ MELEK,SALİM OZAN,FATMA YALÇIN MUSRİ,TURAL DENİZ,GÜNDÜZ ŞEYDA,COŞKUN HASAN ŞENOL. MOLECULAR AND CLINICAL ONCOLOGY, 3(4), 839-842.
2015 - Factors affecting disease free survival in patients with human epidermal growth factor receptor 2 positive breast cancer who receive adjuvant trastuzumab
GÜNDÜZ ŞEYDA,SEZGİN GÖKSU SEMA,ARSLAN DENİZ,ALİ MURAT TATLI,UYSAL MÜKREMİN,UMUT R GÜNDÜZ,SEVİNÇ MM,COŞKUN HASAN ŞENOL,HAKAN BOZCUK,MUTLU HASAN,SAVAŞ BURHAN. MOLECULAR AND CLINICAL ONCOLOGY, 5(3), 1109-1112.
2015 - Fatal posterior revesible leukoencephalopathy syndrome associated coma induced by bevacizumab in metastatic colorectal cancer and review of literature
KARAKURT ERYILMAZ MELEK,MUTLU HASAN,FATMA YALÇIN MUSRİ,KIVRAK SALİM DERYA,COŞKUN HASAN ŞENOL. Journal of oncology pharmacy practic,
2015 - Metronomic oral chemotherapy with old agents in patients with heavily treated metastatic breast cancer
MUTLU HASAN,YALÇIN MUSRİ FATMA,ARTAÇ MEHMET,KARGI AYŞEGÜL,ÖZDOĞAN MUSTAFA,HAKAN BOZCUK. Journal of cancer research and therapeutics, 2(11), 287-290.